|
Washington State Numbers |
1st Qtr |
2ndQtr | 3rd Qtr | 4th Qtr | YTD | |
|
Hospital, Birth Center & Home Births |
20,326 |
20,326 | ||||
|
Specimens Tested (most infants have two newborn screens) |
39,526 |
39,526 | ||||
|
Infants Diagnosed |
1st Qtr |
2ndQtr | 3rd Qtr | 4th Qtr | YTD | |
| Amino Acid disorders | 3 | 3a | ||||
| Biotinidase Deficiency | 0 | 0 | ||||
| Congenital Adrenal Hyperplasia | 2 | 2 | ||||
| Congenital Hypothyroidism | 30 | 30 | ||||
| Cystic Fibrosis | 2 | 2 | ||||
| Fatty Acid Oxidation disorders | 1 | 1b | ||||
| Galactosemia | 0 | 0 | ||||
| Organic Acid disorders | 1 | 1c | ||||
| Severe Combined Immunodeficiency | 0 | 0d | ||||
| Sickle Cell Disease and Other Clinically Significant Hemoglobinopathies | 2 | 2 | ||||
| X-linked adrenoleukodystrophy | 6 | 6e | ||||
| Lysosomal storage disorders | 1 | 11 | ||||
| Total Conditions | 48 | 48 | ||||
| Early Hearing Loss | 11 | 11 | ||||
| All Infants Detected through Newborn Screening | 59 | 59 | ||||
a Three infants with phenylketonuria (PKU) and one infant with tyrosinemia-I (TYR-I).
b One infant with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency.
c One infant with glutaric acidemia type I (GA-I). Excludes one infant with cobalamin C deficiency - a condition not on the panel.
d Excludes one infant with DiGeorge, a condition not on the panel.
e Excludes one infant with peroxisomal biogenesis/function defect - a condition not on the panel.
f Includes one infant with Pompe disease.
Annual screening and disorders statistics
2019 Screening and Disorders Summary (PDF)
2018 Screening and Disorders Summary (PDF)
2017 Screening and Disorders Summary (PDF)
2016 Screening and Disorders Summary (PDF)
2015 Screening and Disorders Summary (PDF)
2014 Screening and Disorders Summary (PDF)
If you have questions regarding the compliance and quality standards for Newborn Screening, please contact us at 206-418-5410 or email at NBS.Prog@doh.wa.gov.